Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;30(10):10.1002/nbm.3754.
doi: 10.1002/nbm.3754. Epub 2017 Jul 5.

Global brain metabolic quantification with whole-head proton MRS at 3 T

Affiliations

Global brain metabolic quantification with whole-head proton MRS at 3 T

Ivan I Kirov et al. NMR Biomed. 2017 Oct.

Abstract

Total N-acetyl-aspartate + N-acetyl-aspartate-glutamate (NAA), total creatine (Cr) and total choline (Cho) proton MRS (1 H-MRS) signals are often used as surrogate markers in diffuse neurological pathologies, but spatial coverage of this methodology is limited to 1%-65% of the brain. Here we wish to demonstrate that non-localized, whole-head (WH) 1 H-MRS captures just the brain's contribution to the Cho and Cr signals, ignoring all other compartments. Towards this end, 27 young healthy adults (18 men, 9 women), 29.9 ± 8.5 years old, were recruited and underwent T1 -weighted MRI for tissue segmentation, non-localizing, approximately 3 min WH 1 H-MRS (TE /TR /TI = 5/10/940 ms) and 30 min 1 H-MR spectroscopic imaging (MRSI) (TE /TR = 35/2100 ms) in a 360 cm3 volume of interest (VOI) at the brain's center. The VOI absolute NAA, Cr and Cho concentrations, 7.7 ± 0.5, 5.5 ± 0.4 and 1.3 ± 0.2 mM, were all within 10% of the WH: 8.6 ± 1.1, 6.0 ± 1.0 and 1.3 ± 0.2 mM. The mean NAA/Cr and NAA/Cho ratios in the WH were only slightly higher than the "brain-only" VOI: 1.5 versus 1.4 (7%) and 6.6 versus 5.9 (11%); Cho/Cr were not different. The brain/WH volume ratio was 0.31 ± 0.03 (brain ≈ 30% of WH volume). Air-tissue susceptibility-driven local magnetic field changes going from the brain outwards showed sharp gradients of more than 100 Hz/cm (1 ppm/cm), explaining the skull's Cr and Cho signal losses through resonance shifts, line broadening and destructive interference. The similarity of non-localized WH and localized VOI NAA, Cr and Cho concentrations and their ratios suggests that their signals originate predominantly from the brain. Therefore, the fast, comprehensive WH-1 H-MRS method may facilitate quantification of these metabolites, which are common surrogate markers in neurological disorders.

Keywords: N-acetyl-aspartate; choline; creatine; diffuse brain disorders; normal brain; proton MRS; whole-head MRS.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Top: WH 1H-MRS from a 2 L phantom (a) and three subjects (b – d, numbers 6, 10 and 16 in Table 1), from the same session as a’ – d’, below (thin black line). All on the same frequency and intensity scales, overlaid with their VeSPA analysis (fit – thick gray line) and residual (raw – fit) from 0 – 4 ppm. Note (i) the vanishing residual, reflecting VeSPA fit’s quality; (ii) excellent lipid suppression performance; and (iii) the qualitative similarity between the WH-1H-MRS brain+head signal, a – d, and localized MRS (brain only) a’ – d’. Bottom, a’ – d’: Raw data (sum of 480 spectra in the 8×10×4.5 cm3 VOI, e.g., Fig. 3d) overlaid with SITools-FITT baseline + model functions from the phantom (a’) and three above subjects (b’ – d’), all on the same frequency and intensity scales. Beneath the spectra is the (raw – fit) residual. Note (i) the vanishing residual, reflecting the fit quality; and (ii) that the WH sequence a 13̅31̅ water and lipids suppressing readout pulse includes the NAA, Cho and Cr in its passband, but excludes the mI at 3.56 ppm [see reference (11); and that despite a linear phase roll across that passband that puts the Cr and Cho peaks almost at an anti-phase, the VeSPA spectral fitting tool and customized basis functions handle this lineshape appropriately, as seen in the figure and quantified at a better than 7% intra-subject inter-scan reproducibility (69)].
Fig. 2
Fig. 2
Top, left: Sagittal (a) and Axial (b) T1-weighted MRI from a male subject superimposed with the 8×10×4.5 cm3 (LR×AP×IS) VOI and 16×16 cm2 axial CSI FOV (solid and dashed lines). The white arrow on a indicates the level of b. Right, c: Real part of the 8×10 axial (LR×AP) 1H spectra matrix from the VOI slice shown on a and marked with the solid white arrow. All spectra are on a common frequency (ppm) and intensity scale. Note the good SNR and excellent spectral resolution (6±2 Hz linewidth) from these high spatial resolution (0.75 cm3) voxels. Bottom, left, d: the sum of all 480 spectra in the VOI (pre-aligned to the NAA peak) (thin black line) overlaid with the spectral fitting (thick gray line). Note the spectral resolution (7±1 Hz linewidth), exceedingly high SNR from this 360 cm3 VOI, and fidelity of the fit.
Fig. 3
Fig. 3
Box plots showing the first, second (median) and third quartiles, ±95th percentiles (whiskers), outliers (*) and means (+) of the WH and VOI absolute NAA, Cr and Cho concentrations distribution in N=27 and N=23 subjects. Note the (i) median and mean proximity, suggesting a normal distribution; (ii) that although the WH NAA and Cr is significantly higher than in the VOI (marked by arrows) they are nevertheless of similar magnitude: 12%, 9% and 3% (Cho) differences between their means in the WH and VOI.
Fig. 4
Fig. 4
Box plots of the Cho/Cr, NAA/Cr and NAA/Cho ratios distributions obtained with WH 1H-MRS (gray), N=27 and with 3D 1H-MRSI from a VOI inside the brain (N=23). Note (i) similar WH and VOI Cho/Cr; (ii) median and mean proximity, suggesting normal distributions; (iii) Although WH and VOI NAA/Cr and NAA/Cho are technically “different” (marked by arrows), these differences are minimal, 7% and 11%, not the expected ~300%. The similarities suggest that WH 1H-MRS comprises overwhelmingly brain, not other head tissue metabolites’ signals.
Fig. 5
Fig. 5
Top, a: Sagittal B0 shift (ΔB0) maps from a 29-year-old female (number 9 in Table 1) at (2 mm)3 spatial resolution. The b – o scale (gradations at 1 cm steps) indicates the levels of the axial ΔB0 maps: b – o, below Bottom, b – o: Axial ΔB0 maps corresponding to the levels of the scale on a, above, extending from the vertex to the foernum magnum. Note (i) the small ΔB0s reflecting relatively uniform field, with only small, ≤10 Hz, variations within the brain – cerebrum and cerebellum; and (ii) the dramatically larger, ›100 Hz/cm variations at the brain-skull-air transitions and near internal air-tissue interfaces, e.g., ear canals, air-filled sinuses and face (slices m – o). These are likely responsible for effectively suppressing the Cho and Cr signals from these transition regions.
Fig. 6
Fig. 6
Histogram of the WH 3.65×105 pixels B0 shifts (ΔB0) distribution of the subject in Fig. 5 (number 9 in Table 1) at 10 Hz/bin resolution. Note (i) that the dominant first bin, comprises 145×104 pixels (1160 cm3) with the most homogeneous, ΔB0≤±10 Hz, (corresponds to local susceptibility ≤0.08 ppm/cm) equals ~90% of her brain volume, therefore, likely originate in the gray regions in Fig. 5, i.e., just the brain. Therefore, the rest of the pixels that sustain greater local ΔB0s must comprise compartments extraneous to the brain (see Fig. 5) and their metabolites signal is lost to susceptibility broadening and shifts.

Similar articles

Cited by

References

    1. Zhu H, Barker PB. MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol. 2011;711:203–226. - PMC - PubMed
    1. Mountford CE, Stanwell P, Lin A, Ramadan S, Ross B. Neurospectroscopy: the past, present and future. Chem Rev. 2010;110(5):3060–3086. - PubMed
    1. Benarroch EE. N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology. 2008;70(16):1353–1357. - PubMed
    1. Yuksel C, Ongur D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry. 2010;68(9):785–794. - PMC - PubMed
    1. Delcker A, Turowski B, Mihm U, Raab P, Rusch O, Pilatus U, Zeuzem S, Zanella FE. Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study. Metab Brain Dis. 2002;17(2):103–111. - PubMed

LinkOut - more resources